Search Tag: CVD
2019 02 Oct
Despite underlying physiological differences and a different set of risk factors, diagnosis, management, and treatment strategies for hypertension do not account for sex and gender variances. Evidence-based guidelines for hypertension treatment from clinical trials are similar between males and females; however, most of these trials do not...Read more
2019 02 Oct
Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines...Read more
2019 26 Aug
Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and...Read more
2019 26 Aug
Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation. Where Are We Now? Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)...Read more
2019 26 Aug
Summary: Differences in sex and gender may account for gaps in treatment and prevention of cardiovascular disease, but at the same time, it also gives the opportunity for personalised sex and gender-specific medicine. Typical presentations in medicine are defined in ways that health care professionals can draw on past experiences and education...Read more
2019 26 Aug
Summary: Cardiovascular disease prevention strategies in 2019 remain a major healthcare issue, requiring an individualised approach for diagnostic and therapeutic decision making. Introduction Since investigators from the Framingham Heart Study first confirmed the existence and importance of cardiovascular disease (CVD) risk factors in...Read more
2019 26 Aug
Summary: Nuclear cardiology is a promising field located between research, imaging, and patient care. Through close interdisciplinary cooperation, a variety of cardiovascular diseases (eg coronary artery, inflammatory and infiltrative cardiac diseases) can not only be investigated, but also efficiently treated in daily clinical routine. What...Read more
2019 26 Aug
How can we get the most common, costly, and modifiable cardiovascular risk factor under control? Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor...Read more
2016 16 Aug
Despite cancer accounting for less than half the number of deaths than CVD in Europe as a whole, in nine of the 15 countries which were members of the European Union before 2004 (EU-15) and in another country that was among those that joined the EU afterwards (EU-28), more men now die from cancer than CVD. These countries are: Belgium, Denmark,...Read more